Exploring the clinical trials, regulatory insights, and challenges of PROTACs in oncology.

Summary: Cancer is a tricky disease. Sometimes, standard treatments stop working because cancer cells learn to fight them off. Now, scientists have a cool new tool called PROTACs. Instead of just blocking the bad cancer proteins, PROTACs act like tiny garbage trucks. They grab the bad proteins and drag them into the cell's trash can to be completely destroyed! This review looks at how these new drugs are doing in clinical trials, the rules for getting them approved by the government, and the hurdles they still face. So far, the results are very promising and offer exciting new hope for cancer patients.